This 2022 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef
This 2022 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef
This 2022 Recommendation Statement from the US Preventive Services Task Force recommends against screening for COPD in asymptomatic adults (D recommendation).
This 2022 Recommendation Statement from the US Preventive Services Task Force concludes that the net benefit of low-dose aspirin use in adults aged 40 to 59 yea
This 2022 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benef